Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCT

Clinical trial NCT00482053 · TERMINATED

Trial details

NCT number: NCT00482053
Sponsor: Stanford University
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, B-cell Lymphoma, Non-Hodgkin Diffuse Large B-cell Lymphoma (DLBCL)Malignant Lymphoma, Non-Hodgkin

Start date: 2006-10-01
Primary completion: 2010-05-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.